Concepedia

Naoya Fujita

NF

149

Publications

14K

Citations

68

H-Index

1987

Active since

Affiliations

Japanese Foundation For Cancer Research(Current)

The University of Tokyo

Kyoto University

The Cancer Institute Hospital

Naoya Fujita is an author at Japanese Foundation For Cancer Research specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

1987–2025

149

Publications

149

Modulation of Akt kinase activity by binding to Hsp90

Saori Sato, Naoya Fujita, Takashi Tsuruo · Proceedings of the National Academy of Sciences · 2000 · 951 citations · Full text

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

Luc Friboulet, Nanxin Li, Ryohei Katayama et al. · Cancer Discovery · 2014 · 820 citations · Full text

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

Ken Uchibori, Naohiko Inase, Mitsugu Araki et al. · Nature Communications · 2017 · 402 citations · Full text

Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow

Mika Shimonaka, Koko Katagiri, Toshinori Nakayama et al. · The Journal of Cell Biology · 2003 · 354 citations · Full text

, , +21

Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization

Naoya Fujita, Saori Sato, Kazuhiro Katayama et al. · Journal of Biological Chemistry · 2002 · 351 citations · Full text

Rows per page

1–5 of 149